Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 32, Issue 7

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 32, Issue 7 (2023)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 32, Issue 7 (2023)

See all volumes and issues

Vol 33, 2024 Volume 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

What is the progress of experimental drug development for fibromyalgia?

Kim Lawson

Pages: 563-565

Published online: 27 Jun 2023

First Page PreviewforWhat is the progress of experimental drug development for fibromyalgia? | Full Text | References | PDF (170 KB) | EPUB

1980 Views
0 CrossRef citations
0Altmetric

Free Access

Editorial

Long COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complications

Fabio Angeli, Paolo Verdecchia & Gianpaolo Reboldi

Pages: 567-570

Published online: 03 Jul 2023

AbstractforLong COVID [post-acute sequelae of coronavirus disease 2019]: experimental drugs for cardiopulmonary complications | Full Text | References | PDF (1.4 MB) | EPUB

706 Views
1 CrossRef citations
0Altmetric

Free Access

Drug Evaluation

Review Article

RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease

Pavel Strnad & Javier San Martin

Pages: 571-581

Published online: 24 Jul 2023

AbstractforRNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease | Full Text | References | PDF (4.3 MB) | EPUB

296 Views
0 CrossRef citations
0Altmetric

Review

Review Article

Psoriasis: a focus on upcoming oral formulations

Lluís Rusiñol, Elena Carmona-Rocha & Lluís Puig

Pages: 583-600

Published online: 01 Aug 2023

AbstractforPsoriasis: a focus on upcoming oral formulations | Full Text | References | PDF (4 MB) | EPUB

453 Views
1 CrossRef citations
0Altmetric

Review Article

Investigational drugs for the treatment of scleroderma: what’s new?

Jelena Colic, Corrado Campochiaro, Michael Hughes, Marco Matucci Cerinic & Lorenzo Dagna

Pages: 601-614

Published online: 08 Aug 2023

AbstractforInvestigational drugs for the treatment of scleroderma: what’s new? | Full Text | References | PDF (2.1 MB) | EPUB

336 Views
0 CrossRef citations
0Altmetric

Review Article

Autoimmune blistering diseases: promising agents in clinical trials

Henning Olbrich, Christian D. Sadik & Enno Schmidt

Pages: 615-623

Published online: 07 Aug 2023

AbstractforAutoimmune blistering diseases: promising agents in clinical trials | Full Text | References | PDF (1.9 MB) | EPUB

363 Views
0 CrossRef citations
0Altmetric

Review Article

Clinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies

Francesco Panza, Vittorio Dibello, Rodolfo Sardone, Fabio Castellana, Roberta Zupo, Luisa Lampignano, Ilaria Bortone, Roberta Stallone, Nicoletta Cirillo, Christian Damiani, Mario Altamura, Antonello Bellomo, Antonio Daniele, Vincenzo Solfrizzi & Madia Lozupone

Pages: 625-634

Published online: 10 Jul 2023

AbstractforClinical development of passive tau-based immunotherapeutics for treating primary and secondary tauopathies | Full Text | References | PDF (311.1 KB) | EPUB

378 Views
0 CrossRef citations
0Altmetric

Review Article

Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments

Zachary Melchiode, Tivoli Nguyen, Omar Dawood, Graham A. Bobo & Wayne J.G. Hellstrom

Pages: 635-642

Published online: 01 Aug 2023

AbstractforPhosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments | Full Text | References | PDF (482.4 KB) | EPUB

115 Views
0 CrossRef citations
0Altmetric

Review Article

Experimental drugs for the prevention or treatment of sensorineural hearing loss

Judith S Kempfle & David H. Jung

Pages: 643-654

Published online: 20 Aug 2023

AbstractforExperimental drugs for the prevention or treatment of sensorineural hearing loss | Full Text | References | PDF (1.1 MB) | EPUB

2236 Views
0 CrossRef citations
0Altmetric

Open Access

Systematic Review

Review Article

Experimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review

Shin Jie Yong, Alice Halim, Michael Halim, Long Chiau Ming, Khang Wen Goh, Mubarak Alfaresi, Bashayer M. AlShehail, Mona A. Al Fares, Mohammed Alissa, Tarek Sulaiman, Zainab Alsalem, Ameen S. S. Alwashmi, Faryal Khamis, Nawal A. Al Kaabi, Hawra Albayat, Ahmed Alsheheri, Mohammed Garout, Jameela Alsalman, Amal H. Alfaraj, Mashael Alhajri, Kuldeep Dhama, Lamees M. Alburaiky, Ahlam H. Alsanad, Abdelmunim T. AlShurbaji & Ali A. Rabaan

Pages: 655-667

Published online: 04 Aug 2023

AbstractforExperimental drugs in randomized controlled trials for long-COVID: what’s in the pipeline? A systematic and critical review | Full Text | References | PDF (745.1 KB) | EPUB

590 Views
3 CrossRef citations
0Altmetric

Original Research

Article

Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study

Jinjie He, Weijuan Du, Haijing Yang, Jingjing Wang, Chenghang Cai, Qingyang Ma, Nanyang Li, Jicheng Yu, Xiaojie Wu, Jufang Wu, Yuancheng Chen, Guoying Cao & Jing Zhang

Pages: 669-675

Published online: 29 Jun 2023

187 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity

Robert H. Gaffey et al.

Review Article | Published online: 17 Jul 2024

Safety, tolerability and pharmacokinetics of ASC10, a novel oral double prodrug of a broad-spectrum antiviral agent, β-d-N4-hydroxycytidine: results from a randomized, double-blind, placebo-controlled phase 1 study in Chinese healthy subjects

Jian Liu et al.

Article | Published online: 12 Jul 2024

Open Access

Medical treatments for abdominal aortic aneurysm: an overview of clinical trials

Jinyi Chen et al.

Review Article | Published online: 11 Jul 2024

Open Access

Emerging treatment landscape for Guillain-Barré Syndrome (GBS): what’s new?

Alina Sprenger-Svačina et al.

Report | Published online: 10 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.32, Iss.7, 2023)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?